Skip to main content

Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies

  • Conference paper
Acute Leukemias II

Abstract

In addition to all the biological properties and clinical features of individual patients with acute leukemia, the quality of therapy itself has evolved as the most relevant predictive factor for cure or failure. Leukemia is still a life-threatening condition and needs adequate management, irrespective of the phenotypic or genotypic characterization of the leukemic clone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Freeman AI, Weinberg V, Brecher ML et al. (1983) Comparison of intermediate dose methotrexate with cranial irradiation for the post-induction treatment of acute lympho¬cytic leukemia in children. N Engl J Med 308: 477 - 484

    Article  PubMed  CAS  Google Scholar 

  2. Henze G, Langermann HJ, Bramswig J et al. (1981) Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukamie bei Kindern und Jugendlichen. Klin Padiatr 193: 145 - 154

    Article  PubMed  CAS  Google Scholar 

  3. Henze G, Langermann HJ, Fengler R et al. (1982) Therapiestudie BFM 79/81 zur Be-handlung der akuten lymphoblastischen Leukamie bei Kindern und Jugendlichen: in- tensivierte Reinduktionstherapie fur Patien- tengruppen mit unterschiedlichem Rezidiv- risiko. Klin Padiatr 194: 195 - 203

    Article  PubMed  CAS  Google Scholar 

  4. Henze G, Langermann HJ, Bramswig J et al. (1983) Ergebnisse der praventiven Behand¬lung des Zentralnervensystems bei 275 Kindern mit akuter lymphoblastischer Leuk¬amie. Klin Padiatr 195: 168 - 175

    Article  PubMed  CAS  Google Scholar 

  5. Langermann HJ, Henze G, Wulf M, Riehm H (1982) Abschatzung der Tumorzellmasse bei der akuten lymphoblastischen Leukamie im Kindesalter: prognostische Bedeutung und praktische Anwendung. Klin Padiatr 194: 209 - 213

    Article  PubMed  CAS  Google Scholar 

  6. Moe PJ, Seip M, Finne PH et al. (1984) Inter-mediate dose methotrexate in childhood acute lymphocytic leukemia. Eur Paediatr Haematol Oncol 1: 1 - 6

    Google Scholar 

  7. Nesbit ME, Sather HN, Robinson LL et al. (1983) Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia. J Clin Oncol 1:308- 316

    Google Scholar 

  8. Riehm H, Gadner H, Henze G et al. (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970-1976. Am J Pediatr Hematol Oncol 2: 299 - 306

    Google Scholar 

  9. Riehm H, Gadner H, Henze G et al. (1983) Acute lymphoblastic leukemia: treatment re¬sults in three BFM studies (1970-1981). In: Murphy SB, Gilbert JR (eds) Leukemia research: advances in cell biology and treat¬ment. Elsevier, Amsterdam, pp 251 - 263

    Google Scholar 

  10. Riehm H, Feickert HJ, Lampert F (1986) Acute lymphoblastic leukemia. In: Voute PA, Barrett A, Bloom HJG, Lemerle J, Neidhardt MK (eds) Cancer in children. Clinical man¬agement, 2nd ed. Springer, Berlin Heidelberg New York, pp 101 - 118

    Google Scholar 

  11. Riehm H, Reiter A, Schrappe M et al. (1986) Die Corticosteroid-abhangige Dezimierung der Leukamiezellzahl im Blut als Prognose- faktor bei der akuten lymphoblastischen Leukamie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Padiatr 99: 151 - 160

    Google Scholar 

  12. Schrappe M, Beck J, Brandeis WE etal. (1987) Die Behandlung der akuten lympho¬blastischen Leukamie im Kindes- und Ju- gendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81. Klin Paditr 199: 133 - 150

    Article  CAS  Google Scholar 

  13. Sullivan MP, Chen T, Dyment PG etal. (1982) Equivalence of intrathecal chemother¬apy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia. A Pediatric Oncology Group Study. Blood 60: 948-958

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Riehm, H. et al. (1990). Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_81

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74643-7_81

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50984-4

  • Online ISBN: 978-3-642-74643-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics